Structure via PubChem · Public domain (PubChem)
peramivir
Sign in to saveAlso known as BCX-1812, 3-(1'-acetylamino-2'-ethyl)butyl-4-((aminoimino)methyl)amino-2-hydroxycyclopentane-1-carboxylic acid, BCX 1812, BCX1812, RWJ 270201, RWJ270201, RWJ-270201, peramivir anhydrous
thumb|Exterior of Rapiacta I.V. Bag 300mg (Generic name: Peramivir hydrate). An anti-influenza virus drug administered by intravenous infusion in Japan.
In the Vinony graph
Within Vinony's link graph, peramivir is referenced by 212 other articles, and connects out to influenza, 1918–1920 flu pandemic and 2009 swine flu pandemic.
It is catalogued under topics including Acetamides, Chemical articles with multiple CAS registry numbers and Chemicals using indexlabels.
Its subject is documented across 14 Wikipedia language editions.
Chemical data
- Formula
- C15H28N4O4
- Molecular weight
- 328.41 g/mol
- IUPAC name
- (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid
- SMILES
- CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C
- InChIKey
- XRQDFNLINLXZLB-CKIKVBCHSA-N
- XLogP
- 0
- Polar surface area
- 151 Ų
- H-bond donors
- 5
- H-bond acceptors
- 5
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2014
- Admin. routes
- parenteral
- Indications
- viral disease, influenza
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 328.211
- Has use
- medication
Show 6 more facts
- chemical formula
- C₁₅H₂₈N₄O₄
- canonical SMILES
- CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C
- Commons category
- Peramivir
- isomeric SMILES
- CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O
- medical condition treated
- influenza
- subject has role
- antiviral drug
via Wikidata · CC0
~4 min read
Encyclopedic overview
3 sectionsContents
- History
- References
- External links
thumb|Exterior of Rapiacta I.V. Bag 300mg (Generic name: Peramivir hydrate). An anti-influenza virus drug administered by intravenous infusion in Japan.
Peramivir (trade name Rapivab) is an antiviral drug developed by BioCryst Pharmaceuticals for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. It is approved for intravenous administration.
Excerpted from Wikipedia’s “peramivir” article, available under the CC BY-SA 4.0 licence.